Julian Brody represents public and private companies on corporate and securities law matters, including disclosure, corporate governance, and SEC compliance.
Julian also advises companies and underwriters on a variety of capital markets transactions, with a focus on initial public offerings, secondary and follow-on offerings, at-the-market offerings, high-yield and investment-grade debt offerings, convertible debt offerings and other capital-raising transactions. His public company clients include US Nasdaq and New York Stock Exchange-listed companies across a broad range of industries, including life sciences, technology, REITs and energy.
Experience
Julian has experience in a variety of industries, including life sciences, technology, REIT and energy. His experience includes representing:
Life Sciences
Avidity Biosciences in its US$200.0m at-the-market offering
Bionomics in its US$20.0m IPO
CG Oncology in its US$204.4m IPO
Gritstone Bio in its US$32.5m follow-on offering, US$45.0m PIPE financing and US$100m at-the-market offering
HilleVax in its US$100.0m IPO
Icosavax in its US$182.0m IPO
Orbital Therapeutics in its US$270.0m Series A preferred stock financing
The underwriters in CG Oncology’s US$204.4m follow-on offering
The underwriters in Janux Therapeutics’ US$222.0m IPO and US$350.0m follow-on offering
The agent in Janux Therapeutics’ US$150.0m at-the-market offering
The underwriters in ImmunoGen’s US$325.0m follow-on offering
The underwriters in Immunome’s US$150.0m and US$200.0m follow-on offerings
The underwriters and the agent in Nyxoah’s US$49.7m follow-on offering and US$50.0m at-the-market offering
The underwriters and the placement agents in Structure Therapeutics’ US$185.3m IPO, US$300.0m PIPE financing and US$476.0m follow-on offering
The underwriters in Travere Therapeutics’ US$125.0m follow-on offering
Technology
Alkami Technology in the following transactions:
US$300.0m convertible notes offering
US $281.3m secondary offering
US$155.9m secondary offering
Health Catalyst’s US$225.0m follow-on offering
High Trail Capital, an investment fund, in the purchase of US$69.0m of convertible notes of MicroVision
Nextiva in its US$200.0m convertible preferred stock financing
The underwriters in GlobalFoundries’ $950.0m follow-on offering
The underwriters in LegalZoom’s US$535.0m IPO
The underwriters in Snap One Holdings’ US$249.3m IPO
REIT
American Assets Trust in its US$525.0m senior notes offering and its US$250.0m at-the-market offering
Essex Property Trust in its aggregate US$550.0m senior notes offering
Extra Space Storage in its US$400.0m senior notes offering
Energy
Sempra in various notes offerings and at-the-market offerings, raising more than US$7.6b
San Diego Gas & Electric in various bond offerings, raising more than US$1.5b
Southern California Gas in various bond offerings, raising more than US$2.2b
High Trail Capital, an investment fund, in the following transactions:
Purchase of US$142.25 million Series F Convertible Preferred Shares of Prairie Operating Co.
Purchase of US$500.0 million senior convertible note of Tellurian
Qualifications
Bar Qualification
California
Education
J.D., University of Michigan Law School, 2013 cum laude
Firm honored by Law360 for advising startups, financial institutions, VCs, digital asset and Web3 participants, and corporations on their most innovative and complex transactions, investigations, litigation, and regulatory matters.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.